ALKEM LABS LTD FDA Approval ANDA 211563

ANDA 211563

ALKEM LABS LTD

FDA Drug Application

Application #211563

Documents

Letter2020-05-15

Application Sponsors

ANDA 211563ALKEM LABS LTD

Marketing Status

None (Tentative Approval)001

FDA Submissions

UNKNOWN; ORIG1TA2020-04-09STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

ALKEM LABS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211563
            [companyName] => ALKEM LABS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE","activeIngredients":"DAPAGLIFLOZIN;METFORMIN HYDROCHLORIDE","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/09\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/211563Orig1s000TAltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-04-09
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.